(LFA-1) 2Β L Α Integrin Subunit I Domain in Regulation of 2Β The

Total Page:16

File Type:pdf, Size:1020Kb

(LFA-1) 2Β L Α Integrin Subunit I Domain in Regulation of 2Β The The Role of the CPNKEKEC Sequence in the β2 Subunit I Domain in Regulation of Integrin αLβ2 (LFA-1) This information is current as Tetsuji Kamata, Kenneth Khiem Tieu, Takehiko Tarui, of September 27, 2021. Wilma Puzon-McLaughlin, Nancy Hogg and Yoshikazu Takada J Immunol 2002; 168:2296-2301; ; doi: 10.4049/jimmunol.168.5.2296 http://www.jimmunol.org/content/168/5/2296 Downloaded from References This article cites 43 articles, 27 of which you can access for free at: http://www.jimmunol.org/content/168/5/2296.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. ␤ The Role of the CPNKEKEC Sequence in the 2 Subunit I ␣ ␤ 1 Domain in Regulation of Integrin L 2 (LFA-1) Tetsuji Kamata,2* Kenneth Khiem Tieu,* Takehiko Tarui,* Wilma Puzon-McLaughlin,* Nancy Hogg,† and Yoshikazu Takada2* ␣ ␣ ␤ The L I (inserted or interactive) domain of integrin L 2 undergoes conformational changes upon activation. Recent studies show ␣ ␤ that the isolated, activated L I domain is sufficient for strong ligand binding, suggesting the 2 subunit to be only indirectly ␣ ␤ involved. It has been unclear whether the activity of the L I domain is regulated by the 2 subunit. In this study, we demonstrate ␤ ␤ that swapping the disulfide-linked CPNKEKEC sequence (residues 169–176) in the 2 I domain with a corresponding 3 sequence, 2؉ ␤ ␣ 174 or mutating Lys to Thr, constitutively activates L 2 binding to ICAM-1. These mutants do not require Mn for ICAM-1 2؉ binding and are insensitive to the inhibitory effect of Ca . We have also localized a component of the mAb 24 epitope (a reporter Downloaded from ␤ 173 175 ␤ of 2 integrin activation) in the CPNKEKEC sequence. Glu and Glu of the 2 I domain are identified as critical for mAb ␤ 24 binding. Because the epitope is highly expressed upon 2 integrin activation, it is likely that the CPNKEKEC sequence is ␣ exposed or undergoes conformational changes upon activation. Deletion of the L I domain did not eliminate the mAb 24 epitope. ␣ This confirms that the L I domain is not critical for mAb 24 binding, and indicates that mAb 24 detects a change expressed in ␤ ␤ part in the 2 subunit I domain. These results suggest that the CPNKEKEC sequence of the 2 I domain is involved in regulating ␣ http://www.jimmunol.org/ the L I domain. The Journal of Immunology, 2002, 168: 2296–2301. ␣ ␤ ␣␤ ␣ he integrin L 2 (LFA-1, CD11a/CD18) is an het- domain of the integrin subunits undergoes conformational ␤ ␣ ␤ erodimeric receptor of the 2 integrin family. L 2 is ex- changes on activation. The two different conformations of the in- T pressed on all leukocytes, is crucial to the inflammatory tegrin ␣ subunit I domain (open and closed) have recently been process, and mediates adhesion to ligands ICAM-1, ICAM-2, and defined, and it has been proposed that these two structures repre- ␣ ␤ ICAM-3 (reviewed in Refs. 1–4). The adhesiveness of L 2 can sent the high-affinity and low-affinity conformations, respectively be dynamically regulated by intracellular signals (inside-out sig- (11–13). Recently, Kallen et al. (14) found that a chemical, lova- 2ϩ ␣ ␣ ␤ naling) (5). Activation from the outside of the cell with Mg and statin, binds to the L I domain and blocks L 2-ligand interac- ␣ ␤ by guest on September 27, 2021 EGTA results in the formation of a high-affinity form of L 2,as tion. It is likely that lovastatin blocks the conformational change shown by an increased ability to bind to soluble ICAM-1, and in that occurs when the closed (inactive) form alters to the open (ac- ␣ ␣ the expression of an activation reporter epitope recognized by tive) form. The M and L I domain, with an open and closed mAb 24 (2, 6, 7). mAb 24 was originally proposed to recognize an conformation, has been generated by site-directed mutagenesis ␤ ␣ ␣ ␣ ␣ ␣ epitope common to all 2 integrin subunits ( L, M, X) (6–9). (15, 16). The isolated L I domain with locked open conformation ␣ 3 ␤ The L subunit has an I (inserted or interactive) domain of is sufficient for ligand binding, suggesting that the 2 subunit may ϳ200 amino acid residues that is critically involved in ligand bind- be only indirectly involved in ligand binding (17). ing. The I domain consists of a central ␤ sheet, surrounded by It has been proposed that the integrin ␤ subunit also has an I seven ␣ helices, which is folded as a globular domain (Rossmann- domain structure within the N-terminal region, which has been ␣ ␤ fold). At the top of the globular domain, the I domain has a metal validated in the recent v 3 crystal structure (11, 18). It is unclear ion-dependent adhesive site (MIDAS) that is involved in coordi- ␤ how and whether the 2 subunit I domain is involved in the con- nating cations Mg2ϩ or Mn2ϩ and in binding ligands (10). The I ␣ ␤ formational changes that L 2 undergoes upon activation. We have reported that the disulfide-linked predicted loop of the inte- ␤ grin 3 I domain (the CYDMKTTC sequence) is critically in- *Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037; volved in the ligand binding and specificity of the non-I domain † and Leukocyte Adhesion Laboratory, Imperial Cancer Research Fund, London, integrin ␣ ␤ (19). Also, it has been proposed that the loop is United Kingdom v 3 localized within the putative ligand-binding pocket in the non-I Received for publication June 20, 2001. Accepted for publication December 13, 2001. domain integrin ␣ ␤ (20). The recent ␣ ␤ crystal structure The costs of publication of this article were defrayed in part by the payment of page IIb 3 v 3 charges. This article must therefore be hereby marked advertisement in accordance shows that the CYDMKTTC sequence is actually exposed to the ␤ with 18 U.S.C. Section 1734 solely to indicate this fact. surface in the headpiece of the 3 subunit (18) (Fig. 1). In the 1 This work was supported by National Institutes of Health Grant GM49899 (to Y.T.) present study, we designed mutagenesis experiments to determine and by Department of the Army Grant DAMD17-97-1-7105 (to T.K.). This is pub- the potential function of the disulfide-linked CPNKEKEC se- lication 14111-VB from The Scripps Research Institute. ␤ quence in the 2 subunit I domain. We show that mutation of the 2 Address correspondence and reprint requests to Dr. Yoshikazu Takada, Department ␣ ␤ of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La CPNKEKEC sequence constitutively activates L 2. We propose ␤ Jolla, CA 92037. E-mail address: [email protected], or Dr. Tetsuji Kamata at the that this sequence in the 2 I domain is critically involved in reg- current address: Department of Anatomy, Keio University School of Medicine, 35 ␣ ulating the L subunit I domain. We found that the CPNKEKEC Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. E-mail address: [email protected]. ␤ keio.ac.jp sequence of 2 is part of the mAb 24 epitope, indicating that mAb ␤ 3 Abbreviations used in this paper: I, inserted or interactive; CHO, Chinese hamster 24 detects a change in the 2 I domain and/or in interdomain ovary; MIDAS, metal ion-dependent adhesive site. interaction on activation. Copyright © 2002 by The American Association of Immunologists 0022-1767/02/$02.00 The Journal of Immunology 2297 Materials and Methods Materials ␤ mAb 24 was generated as previously described (6). mAbs IB-4 (anti- 2) ␣ (21) and TS 1/22 (anti- L) (22) were obtained from American Type Cul- ␤ ture Collection (ATCC, Manassas, VA). mAbs MEM-48 (anti- 2) and ␣ MEM-83 (anti- L) (23) were provided by V. Horejsi (Institute of Molec- ular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic). ICAM-1/mouse C␬ fusion protein was obtained from G. Weitz ␤ (Novartis, Basel, Switzerland). Rat anti-mouse 2 mAb (C71/16) was pur- ␤ chased from BD PharMingen (San Diego, CA). Mouse 2 cDNA was obtained from ATCC. ␣ ␤ cDNA construct and expression of L 2 ␣ ␤ ␤ Human L, human 2, and mouse 2 cDNAs were subcloned into pBJ-1 (24), and site-directed mutagenesis was conducted using unique restriction site elimination (25). The presence of mutations was confirmed by DNA ␣ ␤ sequencing. L and 2 cDNAs in the pBJ-1 vector were transfected into Chinese hamster ovary (CHO) cells by electroporation. Flow cytometry was conducted as described (26). In some experiments, 0.5 mM Mn2ϩ was added to induce mAb 24 binding. Downloaded from Adhesion assays ␣ ␤ Adhesion of CHO and K562 cells expressing L 2 to ICAM-1 was assayed as described (27). Briefly, wells of 96-well Immulon-2 plates were coated with goat anti-mouse C␬ chain polyclonal Ab (Caltag Laboratories, South San Francisco, CA; 0.4 ␮g/well in 100 ␮l of PBS), and then with ICAM- 1/mouse C␬ fusion protein (8 ␮g/ml), unless otherwise specified.
Recommended publications
  • An Investigation Into the in Vitro and in Vivo Function of Murine MRP-14 (S100A9)
    An Investigation into the In Vitro and In Vivo Function of Murine MRP-14 (S100A9) Josie A. R. Hobbs March 2003 Supervisors Dr. Nancy Hogg (Cancer Research UK) Prof. Peter Beverley (University College London) This thesis is submitted in part fulfilment of the requirements for the degree of Doctor of Philosophy at the University of London ProQuest Number: U643505 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U643505 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Abstract MRP-14 and its heterodimeric partner, MRP-8 are highly expressed in neutrophils and monocytes where they constitute 40% and 1% of the total cytosolic protein respectively. They are both low molecular weight proteins that belong to the SI GO family of Ca^^-binding proteins. Using the air pouch model of inflammation it has been demonstrated that recombinant murine MRP-14 (rMRP-14) is a potent chemoattractant for myeloid cells in vivo (May, 1999). While rMRP-14 did not directly cause chemotaxis or activation of myeloid cells in vitro, it caused a rapid elevation in the levels of cytokines in air pouch exudate, suggesting that rMRP-14 causes leukocyte influx via an indirect mechanism.
    [Show full text]
  • Non-Cleavable Talin Rescues Defect in the T-Cell Conjugation of T-Cells
    Immunology Letters 172 (2016) 40–46 Contents lists available at ScienceDirect Immunology Letters j ournal homepage: www.elsevier.com/locate/immlet Non-cleavable talin rescues defect in the T-cell conjugation of T-cells deficient in the immune adaptor SKAP1 a,b a,b a,b,∗ Daina Lim , Yuning Lu , Christopher E. Rudd a Cell Signalling Section, Division of Immunology, Department of Pathology, Tennis Court Road, University of Cambridge, Cambridge CB2 1QP, UK b Cambridge Institute of Medical Research, Hills Road, CB2 OXY Cambridge, UK a r a t i b s c t l e i n f o r a c t Article history: While the cytoskeletal protein talin binds to the ␤-chain of LFA-1, the immune cell adaptor SKAP1 (SKAP- Received 13 October 2015 55) binds to the ␣-chain of the same integrin via RapL. Whereas calpain protease cleavage of talin is Received in revised form 2 February 2016 important for LFA-1 activation, it has been unclear whether SKAP1 can alter the function of talin or its Accepted 5 February 2016 associated adaptor RIAM in T-cells. In this paper, we report that Skap1−/− T-cells showed a reduction in Available online 19 February 2016 the translocation of talin and RIAM to the contact interface of T-cells with antigenic beads or dendritic cells (DCs) presenting OVA peptide to OT-1 T-cells. In addition, Skap1−/− T-cells show an altered pattern Keywords: of talin cleavage, while the expression of a cleavage resistant form of talin (L432G) restored the impaired T-cells − − Talin adhesion of OT1 transgenic Skap1 / T-cells with DCs.
    [Show full text]
  • 'T' Domain of LFA-1 in Selective Binding to Ligands ICAM-1 and ICAM-3 R
    Involvement of the 'T' Domain of LFA-1 in Selective Binding to Ligands ICAM-1 and ICAM-3 R. Clive Landis,* Alison McDowall,* Claire L. L. Holness,** Amanda J. Littler,* David L. Simmons,* and Nancy Hogg* * Leukocyte Adhesion Laboratory, Imperial Cancer Research Fund, London WC2A 3PX, United Kingdom; and ~Cell Adhesion Laboratory, Imperial Cancer Research Fund, Institute for Molecular Medicine, Oxford OX3 9DU, United Kingdom Abstract. To analyze the binding requirements of ent on ICAM-3 but not ICAM-1. The epitopes of LFA-1 for its two most homologous ligands, ICAM-1 mAbs YTH81.5 and 122.2A5 were shown to map to and ICAM-3, we compared the effects of various LFA-1 the I domain of the LFA-1 o~ subunit. A third I domain activation regimes and a panel of anti-LFA-1 mAbs mAb, MEM-83, has been previously reported to uni- in T cell binding assays to ICAM-1 or ICAM-3 coated quely activate LFA-1 to bind ICAM-1 (Landis, R. C., on plastic. These studies demonstrated that T cell R. I. Bennett, and N. Hogg. 1993. J. Cell Biol. binding to ICAM-3 was inducible both from the ex- 120:1519-1527). We now show that mAb MEM-83 is terior of the cell by Mn 2+ and from the interior by an not able to stimulate binding of T cells to ICAM-3 agonist of the "inside-out" signaling pathway. T cells over a wide concentration range. Failure to induce bound both ICAM ligands with comparable avidity. A ICAM-3 binding by mAb MEM-83 was not due to a screen of 29 anti-LFA-1 mAbs led to the identification blockade of the ICAM-3 binding site on LFA-1.
    [Show full text]
  • Ligand Intercellular Adhesion Molecule 1 Has a Necessary Role in Activation of Integrin Lymphocyte Function-Associated Molecule
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 5838-5842, June 1993 Immunology Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1 (adhesion/activation epitope/induced fit) CARLOS CABANAS AND NANCY HOGG* Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX, United Kingdom Communicated by Walter F. Bodmer, March 16, 1993 (receivedfor review December 10, 1992) ABSTRACT The signaling that causes the leukocyte inte- MATERIALS AND METHODS grin lymphocyte function-associated molecule (LFA-1) to bind firmly to its ligand intercellular adhesion molecule 1 (ICAM-1) mAbs and ICAM-1. Production, isolation, and character- is transduced indirectly through other T-cell receptors and is ization of mAb 24 has been described (6). Other mAbs used termed inside-out signaling. We show here that the high- were mAb 38 (6) and MHM24 (9), both recognizing the LFA-1 affinity state of LFA-1 is characterized by expression of the a subunit (CDiia); RRi/1, recognizing ICAM-1 (CD54) (10); LFA-1 epitope detected by monoclonal antibody 24. This CD3 mAb UCHT1 (11); and control mAbs 52U (IgGl) and 4U epitope is expressed not in response to the initial agonist- (IgG2a) (unpublished data). mAbs 24, 38, RRi/1, 52U, and mediated signal but when LFA-1 binds to ICAM-1, indicating 4U were used as purified immunoglobulin and the other that ligand binding induces an alteration in LFA-1. As would mAbs were used as tissue culture supernatant. Fab fragments be predicted, the monoclonal antibody 24 epitope is confined to of mAb 24 were prepared by pepsin digestion (1%; wt/wt) of the LFA-1, which is located at the site ofcontact between T cells intact IgGl in order to generate F(ab')2 fragments, which and ICAM-1-expressing transfectants.
    [Show full text]
  • Neutrophils Integrin Mac-1 on 2Β Activator of the the Human S100 Protein MRP-14 Is a Novel
    The Human S100 Protein MRP-14 Is a Novel Activator of the β2 Integrin Mac-1 on Neutrophils This information is current as Rebecca A. Newton and Nancy Hogg of October 1, 2021. J Immunol 1998; 160:1427-1435; ; http://www.jimmunol.org/content/160/3/1427 References This article cites 44 articles, 20 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/160/3/1427.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 1, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Human S100 Protein MRP-14 Is a Novel Activator of the b 1 2 Integrin Mac-1 on Neutrophils Rebecca A. Newton and Nancy Hogg2 The 14-kDa myeloid-related protein (MRP-14) and its heterodimeric partner, MRP-8, are members of the S100 family of calcium- binding proteins (S100A9 and S100A8, respectively).
    [Show full text]
  • Open Space’ Meeting Called on 12 November 2015
    What can Fellows do to support women in the biomedical workforce? A report of an ‘open space’ meeting called on 12 November 2015 1 Introduction On 12 November 2015 the Academy of Medical Sciences held a meeting for women Fellows to come together to discuss the question ‘What can Fellows do to support women in the biomedical workforce?’. Over 60 women Fellows registered to attend the event (see Annex 1 for names) The event was held using an open space format, which allows groups to self-organise and collaborate around a question of shared concern. The day began with an opening circle at which participants called sessions on the topics they wanted to discuss. This report contains reports of these sessions written by the Fellow who called them. Reports of all sessions were not received. It also includes a transcript of the closing session where participants summarised their thoughts about the day and ideas for next steps. Sessions called during the opening circle: • Women’s Attitudes • Sponsorship (vs Mentoring) • Lectures by women for women • How not to be patronising • The token woman • Fellows careers are not over • Recruitment to senior positions • Ambition limitation by social pressure • Networking - the pub? • Work / life balance • Being small • “Calm Down Dear!” - dealing with sexist comments • Deciding whether and when to have children • Invisibility • How do we get more women Fellows? • Changing the culture • Pink princess • Supporting transitions • Do we involve men? How? • Does language matter? • No more 1 in 4 • Science communication at a young age • Quotas? 30% • What when women numerically dominate? • What is special about women in science? • Style 2 Session reports Women’s attitudes 1.
    [Show full text]
  • In Situ Induction of Dendritic Cell–Based T Cell Tolerance in Humanized Mice and Nonhuman Primates
    Published October 24, 2011 Article In situ induction of dendritic cell–based T cell tolerance in humanized mice and nonhuman primates Kyeong Cheon Jung,1,2 Chung-Gyu Park,3,4,8 Yoon Kyung Jeon,1 Hyo Jin Park,1 Young Larn Ban,2 Hye Sook Min,1 Eun Ji Kim,2 Ju Hyun Kim,1 Byung Hyun Kang,2 Seung Pyo Park,7 Youngmee Bae,5 Il-Hee Yoon,3,4,8 Yong-Hee Kim,3,4,8 Jae-Il Lee,8 Jung-Sik Kim,3,4,8 Jun-Seop Shin,3,4,8 Jaeseok Yang,6,9 Sung Joo Kim,10,11 Emily Rostlund,12 William A. Muller,12 and Seong Hoe Park1,2 1Department of Pathology, 2Graduate School of Immunology, 3Department of Microbiology and Immunology, 4Cancer Downloaded from Research Institute, 5Department of Parasitology and Tropical Medicine, and 6Transplantation Research Institute, College of Medicine; and 7National Creative Research Initiative Center for Oxide Nanocrystalline Materials, School of Chemical and Biological Engineering, College of Engineering; Seoul National University, Seoul 151-742, South Korea 8Xenotransplantation Research Center and 9Transplantation Center, Seoul National University Hospital, Seoul 110-744, South Korea 10Department of Surgery and 11Department of Molecular Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, South Korea 12Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611 jem.rupress.org Induction of antigen-specific T cell tolerance would aid treatment of diverse immunological disorders and help prevent allograft rejection and graft versus host disease. In this study, we establish a method of inducing antigen-specific T cell tolerance in situ in diabetic humanized mice and Rhesus monkeys receiving porcine islet xenografts.
    [Show full text]
  • Defective Chemoattractant-Induced Calcium Signalling in S100A9 Null Neutrophils
    Cell Calcium 41 (2007) 107–121 Defective chemoattractant-induced calcium signalling in S100A9 null neutrophils E. McNeill a, S.J. Conway b, H.L. Roderick c, M.D. Bootman c, N. Hogg a,∗ a Leukocyte Adhesion Laboratory, Cancer Research UK London Research Institute (CRUK LRI), 44 Lincoln’s Inn Fields, London WC2A 3PX, UK b Department of Chemistry, School of Chemistry, University of St Andrews, St Andrews KY16 9ST, UK c Laboratory of Molecular Signalling, The Babraham Institute, Babraham, Cambridge CB2 4AT, UK Received 14 March 2006; received in revised form 14 May 2006; accepted 18 May 2006 Available online 30 June 2006 Abstract The S100 family member S100A9 and its heterodimeric partner, S100A8, are cytosolic Ca2+ binding proteins abundantly expressed in neutrophils. To understand the role of this EF-hand-containing complex in Ca2+ signalling, neutrophils from S100A9 null mice were investigated. There was no role for the complex in buffering acute cytosolic Ca2+ elevations. However, Ca2+ responses to inflammatory agents such as chemokines MIP-2 and KC and other agonists are altered. For S100A9 null neutrophils, signalling at the level of G proteins is normal, 2+ as is release of Ca from the IP3 receptor-gated intracellular stores. However MIP-2 and FMLP signalling in S100A9 null neutrophils was less susceptible than wildtype to PLC␤ inhibition, revealing dis-regulation of the signalling pathway at this level. Downstream of PLC␤, there was reduced intracellular Ca2+ release induced by sub-maximal levels of chemokines. Conversely the response to FMLP was uncompromised, demonstrating different regulation compared to MIP-2 stimulation. Study of the activity of PLC product DAG revealed that chemokine-induced signalling was susceptible to inhibition by elevated DAG with S100A9 null cells showing enhanced inhibition by DAG.
    [Show full text]
  • Infection Pneumoniae Streptococcus Recruitment to Lungs During
    The Integrins Mac-1 and α4β1 Perform Crucial Roles in Neutrophil and T Cell Recruitment to Lungs during Streptococcus pneumoniae Infection This information is current as of September 23, 2021. Aras Kadioglu, Katia De Filippo, Mathieu Bangert, Vitor E. Fernandes, Luke Richards, Kristian Jones, Peter W. Andrew and Nancy Hogg J Immunol published online 1 April 2011 http://www.jimmunol.org/content/early/2011/04/01/jimmun Downloaded from ol.1001533 Supplementary http://www.jimmunol.org/content/suppl/2011/04/01/jimmunol.100153 http://www.jimmunol.org/ Material 3.DC1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 23, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published April 1, 2011, doi:10.4049/jimmunol.1001533 The Journal of Immunology The Integrins Mac-1 and a4b1 Perform Crucial Roles in Neutrophil and T Cell Recruitment to Lungs during Streptococcus pneumoniae Infection Aras Kadioglu,* Katia De Filippo,† Mathieu Bangert,* Vitor E.
    [Show full text]
  • Adhesion Remodeling, Resulting in Enhanced T Cell Filamentous Actin
    Signaling Through Integrin LFA-1 Leads to Filamentous Actin Polymerization and Remodeling, Resulting in Enhanced T Cell Adhesion This information is current as of September 28, 2021. Joanna C. Porter, Madelon Bracke, Andrew Smith, Derek Davies and Nancy Hogg J Immunol 2002; 168:6330-6335; ; doi: 10.4049/jimmunol.168.12.6330 http://www.jimmunol.org/content/168/12/6330 Downloaded from References This article cites 30 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/168/12/6330.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Signaling Through Integrin LFA-1 Leads to Filamentous Actin Polymerization and Remodeling, Resulting in Enhanced T Cell Adhesion1 Joanna C. Porter,* Madelon Bracke,* Andrew Smith,* Derek Davies,† and Nancy Hogg2* The integrins can activate signaling pathways, but the final downstream outcome of these pathways is often unclear.
    [Show full text]
  • LFA-1-Induced T Cell Migration on ICAM-1 Involves Regulation of MLCK-Mediated Attachment and ROCK- Dependent Detachment
    Research Article 3123 LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK- dependent detachment Andrew Smith*, Madelon Bracke*,‡, Birgit Leitinger§, Joanna C. Porter¶ and Nancy Hogg** Leukocyte Adhesion Laboratory, Cancer Research UK London Research Institute, Lincoln’s Inn Fields Laboratories, Lincoln’s Inn Fields, London WC2A 3PX, UK *These authors contributed equally to this work ‡Present address: Department Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, PO Box 80082, 3508 TB Utrecht, The Netherlands §Present address: Sackler Institute for Muscular Skeletal Research, Department of Medicine, University College London, 5 University Street, London WC1E 6JJ, UK ¶Present address: MRC Laboratory for Molecular Cell Biology, University College London, Gordon Street, London WC1E 6BT, UK **Author for correspondence (e-mail: [email protected]) Accepted 9 April 2003 Journal of Cell Science 116, 3123-3133 © 2003 The Company of Biologists Ltd doi:10.1242/jcs.00606 Summary This study analyzes signaling events initiated through compartmentalized activity of the two kinases is reflected binding of the leukocyte integrin LFA-1 to ICAM-1, which in their localization within the T cell. Myosin light chain leads to T cell attachment, polarization and random kinase is concentrated at the leading edge, overlapping F- migration. These events are critically dependent on actin, whereas ROCK is more widely distributed in the dynamic changes in the acto-myosin cytoskeleton under the trailing edge of the T cell. Thus these two kinases perform regulation of myosin light chain kinase and ROCK (Rho two different functions in the migrating T cell, with myosin kinase).
    [Show full text]
  • Engagement of Adhesion Molecules (Cdt8, Cdtta, CD45, CD44, and CD58) Enhances Human Immunodeficiency Virus Type T Replication In
    54 Engagement of Adhesion Molecules (CDt8, CDtta, CD45, CD44, and CD58) Enhances Human Immunodeficiency Virus Type t Replication in Monocytic Cells through a Tumor Necrosis Factor-Modulated Pathway Robin J. Shattock, Gian Paolo Rizzardi,* Peter Hayes, Divisions ofInfectious Diseases and Oncology, St. George's Hospital and George E. Griffin Medical School, London, United Kingdom Engagement of monocytic cell membrane proteins was shown to enhance human immunodefi­ ciency virus type 1 (HIV-1) replication in monocytic cells. Cross-linking of CD18, CDlla, or CD45 by immobilized antibodies produced up to an ll-fold enhancement of HIV-1 release in the OM10.1 monocytic cell line in a tumor necrosis factor-a (TNF-a)-dependent manner. In addition, adhesion Downloaded from https://academic.oup.com/jid/article/174/1/54/959003 by guest on 29 September 2021 ofOM10.1 cells to immobilized intercellular adhesion molecule-I (ligand for CDl8/CDlla) induced similar TNF-a-dependent enhancement of HIV-l replication. After phenotypic differentiation of OMlO.l cells, engagement of cell membrane proteins CD18, CD1la, CD44, CD45, or CD58 by soluble antibodies enhanced HIV-1 replication in a TNF-a-dependent manner. These data suggest that cross-linkage of monocytic cell membrane proteins during cell-cell interaction and specifically during antigen presentation to CD4 T cells may enhance HIV-1 replication, facilitating infection of adjacent cells. Human immunodeficiency virus type 1 (HIV-l)-infected HIV-1 replication in infected peripheral blood monocytes. We macrophages are a persistent reservoir ofvirus in tissue during have previously demonstrated for monocytes that adhesion per all stages ofHIV-I infection [1,2], and migration of such cells se, a phenotypic change associated with differentiation, to tis­ is likely to facilitate dissemination of HIV -1 throughout the sue culture plastic and endothelial cells enhances HIV -1 tran­ body.
    [Show full text]